You are here

  • Home
  • Archive
  • Volume 31, Issue Suppl 3
  • 791 Effectiveness and safety of lenvatinib and pembrolizumab (LenPem) therapy for endometrial cancer (EC): Results from a Russian multicenter database

Citation Tools

Article menu

Download PDFPDF

Endometrial cancer
791 Effectiveness and safety of lenvatinib and pembrolizumab (LenPem) therapy for endometrial cancer (EC): Results from a Russian multicenter database
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Tyulyandina A, Kedrova A, Graft N, et al
791 Effectiveness and safety of lenvatinib and pembrolizumab (LenPem) therapy for endometrial cancer (EC): Results from a Russian multicenter database
International Journal of Gynecologic Cancer 2021;31:A123-A124.